CSS LLC’s Maravai LifeSciences MRVI Stock Holding History

CSS LLC’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,597	Closed	-$471K	–	1293
2021 Q3	$471K	Buy	+9,597	New	+$468K	0.02%	651

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OCBV

Ownership Capital B.V. Amsterdam, Netherlands $178M AUM 4.75% 1-Year Est. Return

CSS LLC's MRVI Position: Q4 2021 in Review

CSS LLC sold out of Maravai LifeSciences (MRVI) in Q4 2021, closing a stake of 9,597 shares — an estimated $471K sold.

CSS LLC first reported a position in MRVI in Q3 2021 and held it in 1 quarter. The position peaked at $471K in Q3 2021. 229 funds tracked by Wall St. Rank hold MRVI as of Q4 2021.

CSS LLC reported no remaining Maravai LifeSciences position as of Q4 2021 after selling out during the quarter.
CSS LLC sold 9,597 Maravai LifeSciences shares in Q4 2021, an estimated $471K.
CSS LLC first reported a position in Maravai LifeSciences in Q3 2021 and held it in 1 quarter.
CSS LLC's Maravai LifeSciences position peaked at $471K in Q3 2021.
229 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q4 2021.

Based on CSS LLC's 13F filing for Q4 2021, filed 14 Feb 2022.